Tag: ICH Q1A stability

Stability Commitment Letters in Shelf Life Extension Submissions

When seeking regulatory approval for a shelf life extension, pharmaceutical companies may not always have long-term stability data covering the entire proposed expiry. In such situations, regulatory agencies allow submission of a stability commitment letter—a formal assurance that the sponsor will continue generating supporting data post-approval. This tutorial explores the format, content, and strategy for…

Regulatory Submissions for Shelf Life Extensions, Shelf Life and Expiry

Tips for Managing Stability Data Across Multiple Submissions

Pharmaceutical companies often prepare dossiers for multiple regulatory agencies like the FDA, EMA, ASEAN, and TGA simultaneously. Managing stability data across these submissions requires precision, harmonization, and clarity. This article provides practical how-to strategies for compiling, organizing, and aligning your stability datasets across global submissions. 📝 Understand the Regulatory Nuances First Each region interprets and…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Comparing ICH, WHO, and FDA Stability Guidelines

Stability testing is a cornerstone of pharmaceutical quality assurance, ensuring that drugs retain their intended potency, safety, and efficacy throughout their shelf life. While global harmonization efforts have brought some consistency, significant variations still exist among leading regulatory bodies such as the USFDA, WHO, and ICH. Understanding these differences is crucial for developing a compliant…

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained

ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained ICH Guidelines for API Stability: Q1A–Q1E and Q3C Explained Introduction Stability Studies are a critical part of the pharmaceutical development lifecycle. For active pharmaceutical ingredients (APIs), ensuring the chemical, physical, and microbiological integrity of the drug substance over time is essential to patient safety and product…

ICH Guidelines for API Stability (Q1A–Q1E, Q3C), Stability Studies for APIs